Our Knowledge of the Sector
Capitalizing on experience acquired from dealing with customers and continually analyzing market needs and legislation changes have enabled IBM to develop an end-to-end offer in line with the need of pharmaceutical and life sciences companies to adapt to the new challenges faced by their sector.
This offer covers consulting through to the implementation of innovative technologies and information systems and comprises several stages, which are set out in a proposal entitled "IBM Pharma 2010".
MDTVISION draws on this industrial and legal expertise and on the experience it has itself obtained from working in other major business sectors (the automotive and aerospace industries in particular) to develop its approach and apply the necessary solutions in terms of Product Lifecycle Management (PLM) and Manufacturing Execution Systems (MES).
This offer covers consulting through to the implementation of innovative technologies and information systems and comprises several stages, which are set out in a proposal entitled "IBM Pharma 2010".
MDTVISION draws on this industrial and legal expertise and on the experience it has itself obtained from working in other major business sectors (the automotive and aerospace industries in particular) to develop its approach and apply the necessary solutions in terms of Product Lifecycle Management (PLM) and Manufacturing Execution Systems (MES).
Best practices and technology to support this approach
By combining the expertise of IBM and MDTVISION consultants, IBM's end-to-end approach and MDTVISION's PLM and MES skills, we can help pharmaceutical companies to better understand their needs and identify and apply the best solutions :
By combining the expertise of IBM and MDTVISION consultants, IBM's end-to-end approach and MDTVISION's PLM and MES skills, we can help pharmaceutical companies to better understand their needs and identify and apply the best solutions :
an end-to-end approach to processes to optimize the integration of Research, Development, Production, Sales and Logistics services;
software solutions and IT architecture to meet new standards (in particular, the FDA's New Compliance Agenda 2003) and deal with the increased volume and complexity of data being managed;
implementing Preferred Technology Platforms;
managing the widening range of products and processes.